Ramiah Investment Group’s Moderna MRNA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-5,710
Closed -$608K 73
2024
Q1
$608K Sell
5,710
-239
-4% -$24.1K 0.57% 45
2023
Q4
$592K Buy
5,949
+1,072
+22% +$90.2K 0.56% 43
2023
Q3
$504K Sell
4,877
-868
-15% -$96.8K 0.52% 42
2023
Q2
$698K Buy
+5,745
New +$766K 0.68% 39
2021
Q4
Sell
-4,523
Closed -$1.74M 88
2021
Q3
$1.74M Buy
+4,523
New +$1.67M 1.25% 20

Other funds holding MRNA

Ramiah Investment Group's MRNA Position: Q2 2024 in Review

Ramiah Investment Group sold out of Moderna (MRNA) in Q2 2024, closing a stake of 5,710 shares — an estimated $608K sold.

Ramiah Investment Group first reported a position in MRNA in Q3 2021 and held it in 5 quarters. The position peaked at $1.74M in Q3 2021. 954 funds tracked by Wall St. Rank hold MRNA as of Q2 2024.

  • Ramiah Investment Group reported no remaining Moderna position as of Q2 2024 after selling out during the quarter.
  • Ramiah Investment Group sold 5,710 Moderna shares in Q2 2024, an estimated $608K.
  • Ramiah Investment Group first reported a position in Moderna in Q3 2021 and held it in 5 quarters.
  • Ramiah Investment Group's Moderna position peaked at $1.74M in Q3 2021.
  • 954 funds tracked by Wall St. Rank held Moderna as of Q2 2024.

Based on Ramiah Investment Group's 13F filing for Q2 2024, filed 29 May 2026.